CLNN (Clene Inc.) Net earnings per share (EPS TTM)
A lack of pricing power due to the testing phase limits current revenue for Clene Inc. (CLNN), but future patents will create a monopoly. High R&D costs and stringent FDA oversight establish significant barriers to entry. The rolling 12-month earnings per share illustrates financial stability, where -2.61 serves as the base parameter value. This supports the strategy of combating ALS through nanomedicine and the restoration of neuronal metabolism.
Financial and market metric breakdowns for Clene Inc (CLNN)
- current quotes and average value forecast:
- business market valuation indicators:
- business book valuation details:
- debt and liquidity details:
- earnings and valuation multiples indicators:
CLNN - Company Net Income|Expected Profit Clene Inc.|CLNN - Price to Earnings Multiple|Future Price to Earnings Clene Nanomedicine|CLNN - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Clene Inc.|CLNN - Operating profit before amortization|Net earnings per share (EPS TTM) Clene|CLNN - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months clene.com|CLNN - Earnings growth in current year|Net earnings per share growth forecast for next year Clene Inc.
Initial company analysis:clene.com - CLNN
A portfolio analyst utilizes this metric to assess the creditworthiness and actual profitability of the issuer. The stability of Clene Inc. (CLNN) is supported by the development of innovative nanotherapy to combat ALS and sclerosis. By analyzing the change in EPS over 12 months, an investor observes net income adjusted for the number of shares and one-time write-offs. This indicator measures the actual earnings per share, filtering out market noise. A positive trend confirms the effectiveness of the business model.
Competitors of Clene Inc.
BIIB - Earnings per share for the last twelve months|NBIX (neurocrine.com) - Earnings per share for the last 12 months|RGC: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Axsome (AXSM)|Net earnings per share for the last 12 months ACAD|XENE: Earnings per share for the trailing year|Net earnings per share (EPS TTM) VKTX|Net earnings per share for the last four quarters supernus.com|Earnings per share for the last twelve months Catalyst Pharmaceuticals, Inc. CPRX|DNLI: Earnings per share for the last 12 months|Harmony Pharma - Net earnings per share (EPS TTM)|Biohaven Corp (BHVN) - Net earnings per share for the last 12 months|AMLX (Amylyx Pharmaceuticals) - Net earnings per share for the last 12 months|TRVI - Net earnings per share for the last four quarters|PRAX (Praxis Precision Medicines, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Anavex (AVXL)|Earnings per share for the last twelve months CeriBell Corp (CBLL)|Earnings per share for the last twelve months PRTA (Prothena Biosciences)|Earnings per share for the last twelve months Alector ALEC|ANNX: Earnings per share for the last 12 months|OMER - Earnings per share for the last twelve months|NGNE (Neurogene Inc) - Earnings per share for the last 12 months|AC Immune Corp (ACIU) - Earnings per share for the last twelve months|Earnings per share for the last 12 months VYGR|NMRA (Neumora Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months scilexholding.com SCLX|Net earnings per share for the last 12 months TVGN (Tevogen Bio)|Net earnings per share (EPS TTM) alphacognition.com (ACOG)|Earnings per share for the last twelve months Cognition Therapeutics CGTX|Earnings per share for the trailing year IKT|SAVA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Assertio Holdings, Inc.|COYA: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Vistagen|Earnings per share for the last twelve months Ovid Therapeutics Inc|Earnings per share for the last twelve months ABOS|Net earnings per share (EPS TTM) CRVO|ATHE - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months PepGen PEPG|JUNS: Earnings per share for the last 12 months|Relmada - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Annovis Bio Corporation|GRCE (gracetx.com) - Net earnings per share for the last 12 months|fireflyneuro.com - Earnings per share for the trailing year|KLTO (ANEW Medical) - Net earnings per share (EPS TTM)|NeuroSense Therapeutics, Ltd. (NRSN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings (RVPH)|metaviatx.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NRXS (NeurAxis, Inc.)|HSDT - Net earnings per share for the last 12 months|PASG: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Neuphoria Therapeutics Inc. NEUP|NERV: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Athira Pharma Corp|Earnings per share for the last twelve months Addex Therapeutics|Earnings per share for the last twelve months ALZN|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|protagenic.com - Earnings per share for the last 12 months|Earnings per share for the last twelve months Pasithea Therapeutics Corp. KTTA|CRGT: Earnings per share for the last 12 months|ATXI - Earnings per share for the last twelve months|BCLI (brainstorm-cell.com) - Earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Chromocell Therapeutics Corp (CHRO)|Net earnings per share for the last 12 months ELYM|Net earnings per share (EPS TTM) Intra-Cellular|Earnings per share for the last twelve months Longboard Pharmaceuticals (LBPH)|MRNS (marinuspharma.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months NKGen Biotech NKGN|NeuroBo Pharmaceuticals Inc (NRBO) - Net earnings per one share for the last twelve months|Sage Therapeutics, Inc - Net earnings per share (EPS TTM)|Synaptogenix, Inc (SNPX) - Net earnings per share for the last 12 months|Trevena, Inc. (TRVN) - Earnings per share for the last twelve months|VIGL (Vigil Neuroscience, Inc.) - Earnings per share for the last twelve months|WENA (Anew Medical) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cerevel Therapeutics Inc CERE
